{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:55Z","timestamp":1790516155284,"version":"4.1.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,23]]},"DOI":"10.1182\/blood-2016-11-751024","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T03:00:29Z","timestamp":1484017229000},"page":"1042-1045","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":64,"title":["Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations"],"prefix":"10.1182","volume":"129","author":[{"given":"Soraya","family":"Curiel-Olmo","sequence":"first","affiliation":[{"name":"Cancer Genomics Laboratory, Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufino","family":"Mond\u00e9jar","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Almaraz","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Virgen de la Salud, Toledo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cereceda","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roso","family":"Mar\u00e8s","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Derdak","sequence":"additional","affiliation":[{"name":"Centro Nacional de An\u00e1lisis Gen\u00f3mico\u2013Centre for Genomic Regulation, Barcelona, Spain;"},{"name":"Barcelona Institute of Science and Technology, Barcelona, Spain;"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Campos-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Virgen de la Salud, Toledo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Batlle","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gonz\u00e1lez de Villambros\u00eda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gut","sequence":"additional","affiliation":[{"name":"Centro Nacional de An\u00e1lisis Gen\u00f3mico\u2013Centre for Genomic Regulation, Barcelona, Spain;"},{"name":"Barcelona Institute of Science and Technology, Barcelona, Spain;"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Blanc","sequence":"additional","affiliation":[{"name":"Centro Nacional de An\u00e1lisis Gen\u00f3mico\u2013Centre for Genomic Regulation, Barcelona, Spain;"},{"name":"Barcelona Institute of Science and Technology, Barcelona, Spain;"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Hematology, Hospices Civils de Lyon, University Lyon, Lyon, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Verney","sequence":"additional","affiliation":[{"name":"Department of Pathology and Hematology, Hospices Civils de Lyon, University Lyon, Lyon, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Baseggio","sequence":"additional","affiliation":[{"name":"Hematology Laboratory, Hospices Civils de Lyon, Lyon, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca I.","family":"Camacho","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Universitario de Getafe, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wotherspoon","sequence":"additional","affiliation":[{"name":"The Royal Marsden National Health Service Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliki","family":"Xochelli","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Papadaki","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Evangelismos Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kanellis","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Evangelismos Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"Pathology Unit, Istituto di Ricovero e Cura a Carattere San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Garc\u00eda-Cos\u00edo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose P.","family":"Vaqu\u00e9","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain;"},{"name":"Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Santander, Spain;"},{"name":"Universidad de Cantabria, Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Beltr\u00e1n","sequence":"additional","affiliation":[{"name":"Centro Nacional de An\u00e1lisis Gen\u00f3mico\u2013Centre for Genomic Regulation, Barcelona, Spain;"},{"name":"Barcelona Institute of Science and Technology, Barcelona, Spain;"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Gut","sequence":"additional","affiliation":[{"name":"Centro Nacional de An\u00e1lisis Gen\u00f3mico\u2013Centre for Genomic Regulation, Barcelona, Spain;"},{"name":"Barcelona Institute of Science and Technology, Barcelona, Spain;"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Piris","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain;"},{"name":"Department of Pathology, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain; and"},{"name":"Department of Pathology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111903204999500_B1","author":"Swerdlow"},{"issue":"7","key":"2019111903204999500_B2","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","article-title":"Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features","volume":"95","author":"Kanellis","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"2019111903204999500_B3","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111903204999500_B4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PAS.0000000000000523","article-title":"NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease","volume":"40","author":"Martinez","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2019111903204999500_B5","article-title":"Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies [published online ahead of print June 27, 2016]","author":"Traverse-Glehen","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2019111903204999500_B6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"2019111903204999500_B7","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"issue":"5","key":"2019111903204999500_B8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"issue":"18","key":"2019111903204999500_B9","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019111903204999500_B10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/leu.2014.294","article-title":"The Kr\u00fcppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma","volume":"29","author":"Piva","year":"2015","journal-title":"Leukemia"},{"issue":"24","key":"2019111903204999500_B11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111903204999500_B12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"2019111903204999500_B13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ni1324","article-title":"A unique function for cyclin D3 in early B cell development","volume":"7","author":"Cooper","year":"2006","journal-title":"Nat Immunol"},{"issue":"7360","key":"2019111903204999500_B14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"9","key":"2019111903204999500_B15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"2019111903204999500_B16","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"2019111903204999500_B17","doi-asserted-by":"crossref","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"45","key":"2019111903204999500_B18","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1038\/sj.onc.1208040","article-title":"P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation","volume":"23","author":"Casanovas","year":"2004","journal-title":"Oncogene"},{"issue":"7418","key":"2019111903204999500_B19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"3","key":"2019111903204999500_B20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/modpathol.2009.173","article-title":"Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes","volume":"23","author":"Metcalf","year":"2010","journal-title":"Mod Pathol"},{"issue":"14","key":"2019111903204999500_B21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2016-06-720888","article-title":"Parathyroid hormone\u2013related protein-producing cyclin D3\u2013positive blastoid variant of mantle cell lymphoma with hypercalcemia","volume":"128","author":"Nakayama","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019111903204999500_B22","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood.V98.9.2837","article-title":"Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies","volume":"98","author":"Sonoki","year":"2001","journal-title":"Blood"},{"issue":"12","key":"2019111903204999500_B23","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111903204999500_B24","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2019111903204999500_B25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood-2015-04-643361","article-title":"Recurrent CDKN1B (p27) mutations in hairy cell leukemia","volume":"126","author":"Dietrich","year":"2015","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/8\/1042\/1465340\/blood751024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/8\/1042\/1465340\/blood751024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T03:06:38Z","timestamp":1658372798000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/8\/1042\/36338\/Splenic-diffuse-red-pulp-small-Bcell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,2,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-11-751024","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}